ATI Physical Therapy Net Profit Margin 2020-2024 | ATIP
ATI Physical Therapy net profit margin from 2020 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| ATI Physical Therapy Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-03-31 | $0.71B | $-0.12B | -16.71% |
| 2023-12-31 | $0.70B | $-0.13B | -18.91% |
| 2023-09-30 | $0.68B | $-0.23B | -34.37% |
| 2023-06-30 | $0.66B | $-0.34B | -51.22% |
| 2023-03-31 | $0.65B | $-0.41B | -62.40% |
| 2022-12-31 | $0.64B | $-0.51B | -80.35% |
| 2022-09-30 | $0.63B | $-0.40B | -63.49% |
| 2022-06-30 | $0.63B | $-0.60B | -95.41% |
| 2022-03-31 | $0.63B | $-0.90B | -141.71% |
| 2021-12-31 | $0.63B | $-0.78B | -123.89% |
| 2021-06-30 | $0.46B | $-0.45B | -98.27% |
| 2021-03-31 | $0.41B | $-0.02B | -3.94% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.020B | $0.699B |
| ATI Physical Therapy Inc. is a portfolio company of Advent International as well as provider of outpatient physical therapy services. ATI Physical Therapy Inc., formerly known as Fortress Value Acquisition Corp. II, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $17.425B | 10.54 |
| Quest Diagnostics (DGX) | United States | $15.213B | 15.72 |
| DaVita (DVA) | United States | $12.075B | 15.00 |
| Chemed (CHE) | United States | $8.786B | 27.23 |
| Encompass Health (EHC) | United States | $8.647B | 22.13 |
| Elanco Animal Health (ELAN) | United States | $6.680B | 15.19 |
| Option Care Health (OPCH) | United States | $5.270B | 19.95 |
| RadNet (RDNT) | United States | $3.877B | 104.94 |
| Amedisys (AMED) | United States | $3.018B | 21.38 |
| LifeStance Health (LFST) | United States | $2.668B | 0.00 |
| Astrana Health (ASTH) | United States | $2.125B | 28.74 |
| Addus HomeCare (ADUS) | United States | $1.712B | 24.49 |
| U.S Physical Therapy (USPH) | United States | $1.591B | 42.58 |
| Pennant (PNTG) | United States | $0.628B | 33.19 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.454B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.343B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.025B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.013B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.005B | 0.00 |